Virus-like particles for diagnosing and preventing Rubella

This eBook explores the use of virus‑like particles (VLPs) as an emerging technology for improving diagnostics and vaccine development in infectious diseases, with a focus on rubella. VLPs mimic the structure of native viruses while remaining non‑infectious, enabling strong immune recognition and reliable assay performance. The resource highlights how recombinant rubella VLPs can provide a scalable and consistent alternative to culture‑derived viral materials, supporting immunoassay development and vaccine research.

Discover how with demonstrated performance comparable to native antigens, VLPs offer advantages in reproducibility, manufacturing efficiency, and cost, making them a promising tool for advancing global rubella control strategies.